Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1650-G Vaccine in Stage I-II NSCLC
NCT00654030Phase 2Completed
- Start
- Oct 2006
- Primary completion
- Nov 2009
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of 1650-G in non-small cell lung cancer (NSCLC). Started Oct 2006; status: completed.
02
Drugs
1650-G
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00654030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654030.